Digital Mental Health Games Improve Psychological Outcomes in Youth
THURSDAY, Sept. 26, 2024 -- Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity disorder (ADHD) or depressive disorder, according to a review published online Sept. 23 in JAMA Pediatrics.
Barry R. Bryant, M.D., from Johns Hopkins University in Baltimore, and colleagues conducted a systematic literature review and meta-analysis to identify studies examining the efficacy and moderators of gamified DMHIs for anxiety, depression, and ADHD in randomized clinical trials (RCTs) for children and adolescents.
Based on 27 identified RCTs (2,911 participants across conditions), the researchers found modest significant effects of gamified DMHIs on ADHD (g, 0.28) and depression (g, 0.28). Small, nonsignificant effects were seen for anxiety disorders (g, 0.07). Larger treatment effects were seen for DMHIs for ADHD delivered on a computer and those RCTs that had a greater preponderance of male participants, as well as for DMHIs for depressive disorders that used preset time limits for gamified DMHIs.
"The findings suggest that gamified DMHIs may constitute a key piece of a comprehensive pediatric mental health treatment plan for youth with ADHD or depression, and future research should consider identified moderators to optimize treatment outcomes," the authors write.
One author disclosed ties to Emalex Biosciences, Syneos Health, and Noema Pharma.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
No Adverse Neurodevelopmental Effects Seen From Inhaled Anesthesia in Children Under 2
THURSDAY, Sept. 11, 2025 -- For children younger than 2 years undergoing surgery, no adverse neurodevelopmental effects are seen with the addition of dexmedetomidine and...
Dementia Odds Significantly Increase With More Psychiatric Comorbidities
WEDNESDAY, Sept. 10, 2025 -- Dementia odds significantly increase with the number of psychiatric comorbidities, according to a study published online Sept. 9 in BMJ Mental...
Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder
WEDNESDAY, Sept. 10, 2025 -- A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.